Close Menu

NEW YORK – Bio-Rad Laboratories reported after the close of the market Thursday that its third quarter revenues increased 3 percent year over year reflecting growth across both of its business segments.

The Hercules, California-based life science research tools and diagnostics firm reported total revenues of $560.6 million for the three months ended Sept. 30, up from $545.1 million for the third quarter of 2018. It missed the consensus Wall Street estimate for revenues of $565.0 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.

Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.

Stat News reports some health tech startups are laying off or furloughing workers.

In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.